Company Overview and News

4
Why now is the best time for millennials to find a job | Moneyish - Features, essays, videos and news about money

21h moneyish
The number of job openings hit a record high last month, according to a recent report. Plus, best practices for scoring the job you want
NOC GM.WS.A GM.WS.B GM.WS.C DOW GM GM.WSB

37
DowDuPont Unit to Invest in Flexible Alkoxylation Facility

2018-06-21 zacks
DowDuPont Inc.’s (DWDP - Free Report) subsidiary — The Dow Chemical Company — recently declared plans to invest in an alkoxylation facility on the U.S. Gulf Coast. The move is likely to support global growth in its core end-markets including personal care, infrastructure and home. Additionally, the facility will also support the company’s end-markets where it is strengthening position for its brands such as Triton, Ecosurf, Tergitol, Carbowax and Sentry.
WLK FTI.WI MS.PRE FMC MS.PRF MS.PRG MS.PRA DWDP MS.PRI MS.PRK DOW MS CC

0
Calgary judge awards Dow Chemical $1.06B US in dispute with Nova Chemicals

2018-06-21 cbc.ca
A judge has awarded Dow Chemical Canada $1.06 billion US in damages against Nova Chemicals Corporation in a dispute over a massive ethylene plant in central Alberta.
DOW

0
Dow Chemical wins legal dispute against Nova Chemicals over Alberta plant

2018-06-21 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
DOW

29
Walgreens Stock Replaces GE in the DJIA

2018-06-20 investorplace
Walgreens (NASDAQ:WBA) stock is going to replace General Electric (NYSE:GE) stock in the Dow Jones Industrial Average (DJIA) later this month.
GE GEC PG WBA DOW KO GNE WMT DWDP

16
What GE’s stock being replaced by Walgreens in the Dow Jones Industrial Average may mean - MarketWatch

2018-06-20 marketwatch
General Electric is being replaced by Walgreens Boots Alliance Inc. as one of the 30 components of the 122-year-old Dow Jones Industrial Average.
GEC GE DOW WBA GNE DWDP

26
DowDuPont Unit to Expand Global Glycol Ethers Capacity

2018-06-19 zacks
DowDuPont Inc.’s (DWDP - Free Report) subsidiary — The Dow Chemical Company — has declared a series of phased, incremental investments for expanding its global glycol ethers facility. The move will help the company to address the increasing demand in major end-markets and applications. Once completed, the company’s existing capacity of these product lines is expected to nearly double. Notably, the company intends to boost production capacity of select p-series and performance glycol ethers product lines, which includes Dowanol Glycol Ethers, through a series of seven de-bottlenecking and incremental expansion projects.
WLK FTI.WI FMC DWDP NEE.PRI NEE.PRJ NEE.PRC DOW NEE.PRQ NEE.PRR CC NEE

0
Battle Builds Around a New Product-Labeling Bill in Congress - Bloomberg

2018-06-18 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
DOW

28
An Oil Giant Is Taking Big Steps. Saudi Arabia Can’t Afford for It to Slip. - The New York Times

2018-06-18 nytimes
As the kingdom prepares for its next evolution, Saudi Aramco is central. But a planned public listing leaves the company, and the country, at risk.
RDS.B RDS.A XOM RYDBF DOW RDSB NYTAB RDSA RYDAF

0
DowDuPont: Attractive Valuation

2018-06-11 seekingalpha
The 2017 merger between Dow Chemical and DuPont created DowDuPont (DWDP) as the world's largest chemical company (followed by the German behemoth BASF (OTCQX:BASFY)). Net sales are in excess of $80 billion with global divisions in agriculture, material science, and specialty products. Importantly for investors, the company plans to separate into three separately traded public companies by June 2019.
DOW DWDP

0
Germany-Based Companies Open Lab Space in U.S.

2018-06-06 biospace
There are several recent announcements of German companies opening laboratories in the U.S. It is probably not related to the recent news that the U.S. Justice Department gave Germany-based Bayer and U.S.-based Monsanto the go-ahead for their merger. Due to anti-trust issues, Monsanto has to sell about $9 billion in assets, and European regulators also required the sale of $2.54 billion in assets, which are being sold to BASF.
SYENF DOW SYT

2
RGS Energy to Hold POWERHOUSE™ Business Update Conference Call on Thursday, June 7, 2018 at 4:30 p.m. ET

2018-06-04 globenewswire
DENVER, June 04, 2018 (GLOBE NEWSWIRE) -- RGS Energy (NASDAQ:RGSE), the exclusive worldwide manufacturer of POWERHOUSE™, will hold a conference call on Thursday, June 7, 2018 at 4:30 p.m. Eastern time to discuss the innovative and visually stunning solar shingle system using technology developed by The Dow Chemical Company.
RGSE DOW

1
Ex-chemical industry lawyer to lead Superfund task force

2018-06-01 nzherald.co.nz
WASHINGTON (AP) — A lawyer tapped to lead a task force at the Environmental Protection Agency overseeing cleanups at the nation's most polluted places worked until recently for a top chemical and plastics manufacturer with a troubled legacy of creating some of those toxic sites.
LALWF LYB DOW

0
Minerals Technologies Announces Appointment of Jonathan Hastings as Group President, Performance Materials

2018-06-01 globenewswire
NEW YORK, June 01, 2018 (GLOBE NEWSWIRE) -- Minerals Technologies Inc. (NYSE:MTX) (“MTI” or “the Company”) today announced the appointment of Jonathan Hastings as Group President, Performance Materials, effective June 1, 2018. Mr. Hastings is succeeding Gary Castagna, who retired on May 31, 2018.
MTX DOW

0
DowDupont’s New Profit Formula: Killing More Research Projects - Bloomberg

2018-05-31 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
DOW DWDP

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Silicon Investor Message Boards

This table lists all message boards related to DOW / Dow Chemical Co. (The) on message board site Silicon Investor.

Who Wonu0027t Be Down For Breakfast? Market crash like NOW
Windows 10 Silicon Investor for Windows Phone
Windows Phone Windows 7
Bgt=Smart Cardu0026 Windows 2000 Windows 8
Dow Chemical Co. Rolling Averages, Their ins and outs and ups and downs
CUSIP: 26078J100